This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Fexeric
  • /
  • A Pilot Study of KRX-0502 (Ferric Citrate, Adminis...
Clinical trial

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

Read time: 1 mins
Last updated:1st Apr 2014

The objective of this pilot study is to evaluate the efficacy and safety of KRX-0502, administered without food, in treating iron deficiency anemia in subjects with stage 3 to 5 non-dialysis dependent chronic kidney disease (NDD-CKD).


Study Type: Interventional
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Phase 2 Pilot Study of KRX-0502 (Ferric Citrate Coordination Complex) in Treating Iron-deficiency Anemia in Patients With Stage 3-5 Non-dialysis Dependent Chronic Kidney Disease (NDD-CKD)
Enrollment: 32
Study Start Date: April 2014
Study Completion Date: November 2014
Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
KRX-0502

Category Value
Study start date 2014-04-01

View full details